The global generic sterile injectable market is expected to grow at a significant CAGR during the forecast period (2021-2027). The generic sterile injectable is the biologics that are used to treat a variety of diseases and have the same active ingredients as branded versions, however, the inactive contents of the medications can differ. The major factors influencing the growth of the market is the rising prevalence of chronic diseases and a rapidly ageing population that is especially susceptible to chronic diseases. The rising prevalence of chronic diseases such as cancer, COPD, and diabetes, as well as the resulting increase in demand for newer generic injectables in various European countries, is propelling the growth of the market.
According to the World Health Organization (WHO), the mortality rate of COPD for men and women is about 18 per 1,00,000 inhabitants per year, in Europe. In the same vein, the countries in Europe are experiencing a substantial rise in diabetes cases. According to the WHO, in 2019, Germany had the highest prevalence of diabetes in Europe among the adult population with 15.3% living with diabetes in 2019, Portugal followed with the second-largest share of 14.2%. On the other hand, Ireland has the lowest prevalence of diabetes in Europe at 4.4%. Hence, the rising prevalence of chronic disease is driving the market growth. However, the US FDA has strict rules such as monitoring flexible intravenous (IV) solution bags for microscopic punctures or holes on the surface of the bag during labelling and packaging to minimise microscopic faults that may result in microbial contamination.
Market Coverage
Competitive Landscape: Baxter International Inc., Sanofi S.A., and Pfizer Inc., among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Generic Sterile Injectable Market Report by Segment
By Drug Type
• Monoclonal Antibodies
• Cytokines
• Insulin
• Peptide Hormones
• Vaccines
• Immunoglobulins
• Others (Blood Factors and Peptide Antibiotics)
By Therapeutic Application
• Cancer
• Diabetes
• CVD
• Central Nervous System
• Infectious Diseases
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Global Generic Sterile Injectable Market by Region
North America
Europe
Asia-Pacific
Rest of the World